TREVI THERAPEUTICS, INC.

Profile

Company Names

TREVI THERAPEUTICS, INC.

Addresses

195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT 06510

52 CHARTER RIDGE ROAD, SANDY HOOK, CT 06482

Phone Numbers

203-304-2499

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$128,290,451.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-04-11 
$54,999,998.00 
$54,999,998.00 
$0.00 
Equity 
4
2021-10-18 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
3
2021-10-05 
$11,819,891.00 
$11,819,891.00 
$0.00 
Equity 
2
2017-07-14 
$51,906,460.00 
$61,906,460.00 
$10,000,000.00 
Equity 
1
2012-12-05 
$6,564,102.00 
$13,064,102.00 
$6,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
METTE 
KIRSTINE 
AGGER 
DIRECTOR
ALLOCURE INC   |  SCPHARMACEUTICALS INC.   |  IMARA INC.   |  TREVI THERAPEUTICS, INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
JAMES 
 
CASSELLA 
DIRECTOR
TREVI THERAPEUTICS, INC.
DOMINICK 
 
COLANGELO 
DIRECTOR
TREVI THERAPEUTICS, INC.
LISA 
 
DELFINI 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.
CAYCE 
 
DENTON 
DIRECTOR
TREVI THERAPEUTICS, INC.   |  PATIENTSAFE SOLUTIONS, INC.
WILLIAM 
 
FORBES 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.   |  HALLUX, INC.
JENNIFER 
L. 
GOOD 
EXECUTIVE OFFICER, DIRECTOR
TREVI THERAPEUTICS, INC.
MICHAEL 
 
HEFFERNAN 
DIRECTOR
COLLEGIUM PHARMACEUTICAL INC   |  PRECISION DERMATOLOGY, INC.   |  CORNERSTONE THERAPEUTICS INC   |  GENOME ID GROUP, LLC   |  COLLEGIUM PHARMACEUTICAL, INC   |  EMIND SCIENCE CORP   |  TREVI THERAPEUTICS, INC.   |  CARISMA THERAPEUTICS INC.   |  PAR HEALTH, INC.
ED 
 
MATHERS 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  INTARCIA THERAPEUTICS, INC   |  ENVISIA THERAPEUTICS INC.   |  SYNLOGIC, INC.   |  MIRNA THERAPEUTICS, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  ENVISIA THERAPEUTICS, INC.   |  SYNLOGIC, LLC   |  TREVI THERAPEUTICS, INC.   |  AKOUOS, INC.   |  RENEO PHARMACEUTICALS, INC.   |  SENTI BIOSCIENCES, INC.   |  MIRUM PHARMACEUTICALS, INC.   |  CURZION PHARMACEUTICALS, INC.
EDWARD 
 
MATHERS 
DIRECTOR
RA PHARMACEUTICALS, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SATORI PHARMACEUTICALS INC   |  MIRNA THERAPEUTICS, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  LUMENA PHARMACEUTICALS, INC.   |  LUMOS PHARMA, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  LIQUIDIA TECHNOLOGIES INC   |  INOZYME PHARMA, INC.   |  SYNLOGIC, INC.   |  AFFINIA THERAPEUTICS INC.   |  CODE BIOTHERAPEUTICS, INC.   |  TREVI THERAPEUTICS, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  MBX BIOSCIENCES, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  BRENIG THERAPEUTICS, INC.   |  SENTI BIOSCIENCES, INC.   |  SENTI BIOSCIENCES HOLDINGS, INC.   |  SENTI HOLDINGS, INC.   |  SENTI BIOSCIENCES, INC.
DAVID 
 
MEEKER 
DIRECTOR
INTRINERGY, LLC   |  TREVI THERAPEUTICS, INC.   |  HULL STREET ENERGY PARTNERS III (PARALLEL), L.P.   |  HULL STREET ENERGY PARTNERS III, L.P.
ANNIE 
 
MITSAK 
DIRECTOR
TREVI THERAPEUTICS, INC.   |  ALESSA THERAPEUTICS, INC.   |  TRITON THERAPEUTICS, INC.
ERAN 
 
NADAV 
DIRECTOR
ULTRAGENYX PHARMACEUTICAL INC.   |  TREVI THERAPEUTICS, INC.   |  NOVASOM, INC   |  COLLEGIUM PHARMACEUTICAL, INC   |  CARISMA THERAPEUTICS INC.
THOMAS 
 
SCIASCIA 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.
THOMAS 
R. 
SCIASCIA 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.
CHRIS 
 
SEITER 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.
JOSEPH 
 
SORRENTINO 
EXECUTIVE OFFICER
TREVI THERAPEUTICS, INC.   |  JKL EQUIPMENT LLC
OTELLO 
 
STAMPACCHIA 
DIRECTOR
OMEGA FUND III, L.P.   |  OMEGA FUND II, L.P.   |  TREVI THERAPEUTICS, INC.   |  MORPHIC HOLDING, LLC   |  ESSA PHARMA INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SCORPION THERAPEUTICS, INC.   |  IKENA ONCOLOGY, INC.   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
ANNE 
 
VANLENT 
DIRECTOR
TREVI THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-04-11 
2021-10-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-10-18 
2021-10-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-10-05 
2018-09-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2017-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-14 
2012-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
NONE
NONE
NEEDHAM + COMPANY, LLC
16360
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
AEGIS CAPITAL CORP.
15007